Compare 8x8 Inc (EGHT) vs HCA Health Inc (HCA) Price & Performance

EGHT trades at $2.06, down 8.04% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with five consecutive quarters of revenue growth and consistent earnings beats, though profitability remains thin with a 0.64% net margin. Recent AI product expansions and partner program launches signal strategic growth initiatives. Analyst consensus targets $3.13, representing 52% upside potential from current levels.

EGHT presents a compelling risk-reward profile with significant analyst upside but faces execution risks in a competitive communications sector. The transition to profitability in 2026 forecasts and strong institutional support offset near-term volatility concerns. Key risks include high debt levels and margin pressure, while AI adoption growth and consistent earnings outperformance provide catalysts for valuation expansion.

HCA Healthcare trades at $413.27, down 0.18% on the day, with strong technical momentum showing a bullish moving average signal. The company reported solid Q2 2026 earnings with EPS of $7.59 beating estimates of $7.56, marking the third consecutive quarterly beat. Revenue growth continues with 2025 revenue reaching $75.60 billion, while maintaining healthy profit margins of 8.77%. Recent management appointments and ongoing legal investigations create mixed sentiment around the stock.

HCA presents a compelling value opportunity with attractive valuation multiples (P/E 13.8, EV/EBITDA 8.8) and strong analyst support (63% buy ratings, $449.93 price target). However, investors face risks from multiple ongoing legal investigations, high debt levels (debt-to-asset ratio 80.9% in 2025), and margin pressure from rising operational costs. The stock offers 8.9% upside to consensus target but requires monitoring of legal developments and expense management.